Abstract
Response Patterns and MRD By Flow Cytometry and NGS in Patients with Mutant-IDH Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have